Multiplex Microelectrode Array for Direct Protease Activity Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting protease biomarkers, such as cathepsin B, are limited by their inability to accurately measure the activity of both active and inactive forms, are time-consuming, and require complex sample preparation, making them unsuitable for rapid and sensitive diagnostics.

Innovation Solution

A multiplex microelectrode array (MEA) with peptide-functionalized electrodes is used to directly detect protease activity through electrochemical methods, allowing simultaneous measurement of multiple proteases in a biological sample without significant sample preparation, using a heterogeneous Michaelis-Menten model to derive kinetic constants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional protease detection methods are used, then detection can be performed, but the methods are either non-specific, time-consuming, or unable to accurately measure protease activity in complex biological samples

Engineering Contradiction:
Improveprotease activity measurement accuracyVSAvoiddetection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention divides the detection system into multiple individually addressable microelectrodes (e.g., 3x3 array with 9 electrodes), where each electrode is functionalized with specific peptide substrates for different proteases. This segmentation enables simultaneous multiplex detection of multiple proteases in parallel, dramatically reducing detection time while maintaining high measurement precision through electrode-specific kinetic analysis

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses peptide substrates as intermediaries that specifically bind to target proteases. These peptide intermediaries translate protease activity into measurable electrochemical signals through redox reporters, enabling accurate and specific detection of protease activity in complex biological samples without cross-reactivity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If traditional protease detection methods are used, then detection can be performed, but they are non-specific and unable to accurately measure protease activity

Engineering Contradiction:
Improveprotease detection specificityVSAvoidsensor array complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Each microelectrode in the array is functionalized with specific peptide substrates tailored to detect particular proteases (e.g., cathepsin B, MMP-2, MMP-9). This local functional differentiation ensures high detection specificity for each target protease while the overall array complexity is managed through systematic organization and individual electrode addressability

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention measures kinetic parameters (rate constants, Michaelis-Menten constants) for each electrode-protease interaction to provide quantitative and specific protease activity measurements. By analyzing temporal changes in electrochemical signals and deriving kinetic parameters, the system achieves high reliability in distinguishing specific protease activities from background noise

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If individual protease detection is performed, then specific protease levels can be measured, but multiple separate assays are required and protease levels are extremely low

Engineering Contradiction:
Improveprotease level detection sensitivityVSAvoiddetection throughput
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The invention merges multiple individual protease detection capabilities into a single multiplexed microelectrode array system. Multiple electrodes are simultaneously functionalized with different peptide substrates, allowing parallel detection of multiple proteases in a single assay, thereby increasing throughput while maintaining the sensitivity needed to detect extremely low protease levels through cumulative signal amplification

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The microelectrode array platform provides universal functionality for detecting various proteases (cysteine proteases, serine proteases, metalloproteases) using a common electrochemical detection system. This multi-functional approach enables simultaneous measurement of multiple protease types with a single device, improving productivity while maintaining high measurement precision through standardized kinetic analysis

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The MEA provides sensitive and specific detection of protease activity down to subnanomolar concentrations, enabling rapid and accurate diagnosis of diseases like cancer by measuring active protease levels directly in human serum, complementing traditional affinity-based methods.

Implementation Method 1

electrochemical method based on a peptide-functionalized microelectrode array (MEA) for direct detection enzymatic activity

Methodology Applied
Scientific EffectElectrochemical detection: Redox Reactions

Data Source

PatentUS12618835B2Multiplex microelectrode array for detection of proteases as biomarkers
Publication Date: 2026.05.05 UNITED STATES OF AMERICA AS REPRESENTED BY THE ADMINISTRATOR NAT AERONAUTICS & SPACE ADMINISTRATION
  • US12618835B2 patent drawing
  • US12618835B2 patent drawing
  • US12618835B2 patent drawing

AI summary

An electrochemical method for measuring the activity of biomarkers using microelectrode arrays functionalized with peptide consensus sequences and redox reporter moieties. Contact of the arrays with a biological sample containing one or more target biomarkers results in cleavage of the peptides and changes the electric current across the array in a quantifiable manner indicating not just the presence of the target biomarker in the sample, but its activity.